Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
Go back to Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 320.71 -2.02 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $322.73 | 52 Week High | $141.32 | |||
| Open | $322.00 | 52 Week Low | $97.79 | |||
| Day High | $322.70 | P/E | 51.31 | |||
| Day Low | $319.38 | EPS | $6.25 | |||
| Volume | 1,737,851 | |||||
